CIEL: Intervention Study in Elderly With Sleep Problems

Sponsor
Mirjam Münch (Other)
Overall Status
Recruiting
CT.gov ID
NCT05485415
Collaborator
University of California (Other)
86
2
2
35.5
43
1.2

Study Details

Study Description

Brief Summary

The main objective of the study is to improve subjective sleep quality using a multimodal intervention with an intervention and a control group. The multimodal intervention aims to improve circadian Zeitgeber strength. This will be achieved by optimizing daily light exposure, sleep, physical activity, and mealtimes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Multimodal intervention
  • Behavioral: Control
N/A

Detailed Description

The study lasts for 19 months and contains 7 visits. After the screening visit at the Centre for Chronobiology, Basel, Switzerland, participants are assigned to either the intervention or the control group which is followed by a 7-day baseline week at home and a co-design meeting to provide instructions to the intervention and the control group. At the occasion of 4 visits (spread over 12 months) at the participants' homes, different measurements will be performed such as saliva collection, questionnaires, cognitive performance tests, light and rest-activity measures. A follow-up visit 6 months after completion of the last data collection will provide qualitative feedback by the participants.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
86 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized Clinical Trial with a control groupRandomized Clinical Trial with a control group
Masking:
Single (Participant)
Masking Description:
Participants are unaware whether they are in the intervention or the control group
Primary Purpose:
Other
Official Title:
Personalised Circadian Intervention Study in Elderly With Sleep Problems
Actual Study Start Date :
Jul 15, 2022
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Jun 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intervention

Personalised intervention

Behavioral: Multimodal intervention
Participants in the intervention group will receive personalised advice on sleep, light exposure, meal times and physical activity.

Placebo Comparator: Control

General sleep advice

Behavioral: Control
General sleep advice

Outcome Measures

Primary Outcome Measures

  1. Subjective sleep quality [1 year]

    Pittsburgh Sleep Quality Index (Score > 5 indicates poor sleep)

Secondary Outcome Measures

  1. Sleep timing [1 year]

    Derived from Activity Watches

  2. Subjective wellbeing [1 year]

    Visual Analogue Scales

  3. Salivary melatonin concentration [1 year]

    Circadian phase marker

  4. Pupil size [1 year]

    Pupil response to chromatic light stimuli

  5. Glucose metabolism [1 year]

    HbA1c concentration (blood)

  6. Telomere length [1 year]

    Age marker

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

64 years old women and men

  • Pittsburgh Sleep Quality Index (PSQI) > 5 (indicative of sleep problems)

  • Living at home (including self-serviced retirement apartment)

Exclusion Criteria:
  • Total blindness or VA < 0.5

  • Progressive NCDs (e.g., cancer)

  • Acute infections (e.g., Covid-19)

  • Neurodegenerative disease

  • Psychiatric disease

  • Sleep disorder (sleep apnea, narcolepsy)

  • Not German speaking

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre for Chronobiology, Psychiatric Hospital of the University of Basel Basel BS Switzerland 4002
2 Centre for Chronobiology, Psychiatric Hopspital of the University of Basel Basel Switzerland 4002

Sponsors and Collaborators

  • Mirjam Münch
  • University of California

Investigators

  • Principal Investigator: Mirjam Münch, PhD, Research Associate

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mirjam Münch, Principal Investigator, University Psychiatric Clinics Basel
ClinicalTrials.gov Identifier:
NCT05485415
Other Study ID Numbers:
  • 2022-00904
First Posted:
Aug 3, 2022
Last Update Posted:
Aug 3, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mirjam Münch, Principal Investigator, University Psychiatric Clinics Basel
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2022